Crossmark

Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance

Published Online: 2018-12-18

Published Print: 2018-12

Authors

Hattori, Sachiko https://orcid.org/0000-0002-4580-4382
Clinical Trials ^BETA

Clinical trials referenced in this document:

umin000021552 at UMIN Japan

Documents that mention this clinical trial

Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance
https://doi.org/10.1186/s13098-018-0395-5
License Information

Text and Data Mining valid from 2018-12-01

Version of Record valid from 2018-12-18
More Information

Article History

Received: 26 October 2018

Accepted: 13 December 2018

First Online: 18 December 2018

Document is current